SlideShare a Scribd company logo
JOHN P. HICKEY
3339 Cottonfield Dr. 843-532-9462
Mt. Pleasant, SC 29466 jp1hickey@comcast.net
SUMMARY
An award winning, committed and passionate individual with twenty years of proven success in the
medical device industry. A broad experience including both large and emerging technology companies
in the areas of IDE study recruitment, market development, global sales, management, training,
marketing, and product development. Strengths include excellent communication skills, personnel
management and development of key opinion leaders with adoption of new technology. Areas of
experience include Cardiology, Radiology, General & Vascular Surgery, Gastrointestinal Endoscopy,
and Interventional Bronchoscopy.
CAREER HISTORY
PULMONX CORPORATION, REDWOOD CITY, CA SEPTEMBER 2014 – PRESENT
Pulmonx is a privately-held (OUS) commercial stage medical device company focused on
developing both diagnostic and therapeutic technologies for Interventional Pulmonology. Pulmonx
has developed the Endobronchial Valve (EBV) Therapy, a non-surgical approach to treating
emphysema that uses the Chartis Pulmonary Assessment System to optimize the placement of a
series of unique self-expanding valves. In the United States, Pulmonx is conducting the LIBERATE
Clinical Study to evaluate the safety and effectiveness of the Zephyr valve in patients with severe
emphysema.
Director of Market Development
 Responsible for driving patient enrollment in US IDE study sites thru social media, print media,
patient advocacy organizations, TV news stories, and physician referral networks.
 Achieved and/or exceeded individual quarterly patient enrollment quotas.
 Identify and develop relationships with key institutions and thought leading physicians.
 Experienced in training physicians on the proper use of Pulmonx’s products, and assisting them
as appropriate during the clinical study.
 Work with other functional groups in the company to support regulatory, clinical, and
development activities.
BRONCUS MEDICAL/TECHNOLOGIES INC., MOUNTAIN VIEW, CA MAY 2009 – SEPTEMBER 2014
A venture capital funded medical device company focused on providing a portfolio approach of
devices related to Interventional Pulmonology/Thoracic Surgery. Current development includes
investigation of a novel minimally-invasive treatment option (airway bypass/drug eluding stents) for
patients with emphysema. The organization has US commercial approval to launch imaging
technology (virtual bronchoscopic navigation), tissue sampling and mini-Doppler ultrasound for
diagnosis of lung disease.
Director, Global Sales and Market Development (March 2012 – September 2014)
 Established a team of 4 regional sales managers and 2 marketing managers to focus on
achievement of commercialization objectives across the US.
 Identify and develop key strategic institutions/physicians for reference centers.
 Responsible for product launches in international markets recognizing CE mark approval by
conducting market analysis, developing revenue models, and establishing product champions.
 Identify, train, and manage international distributors to sell in Europe, Asia and South America,
while providing physician proctoring and case coverage.
 Assist with development of marketing and training materials for physicians and distributors.
 Assist with reimbursement strategy/activities in all markets.
Southeast Region Sales Manager (May 2009 - March 2012)
 Responsible for the market development of 2 new medical technologies that provide 3D virtual
bronchoscopic procedure planning and navigation, and a diagnostic biopsy device for lung
disease.
 Assist Global V.P. of Sales in building a direct sales force for US launch of 3 products in 2010.
 Consistently finished #1 in US sales amongst 4 Regions since launch with 12 navigation
systems sold to date.
 Identified market opportunity to separate and expand the company’s platform product into the
radiology market.
 Promoted to Director, Sales & Market Development in March 2012.
ALVEOLUS INC., CHARLOTTE, NC FEBRUARY 2008 - APRIL 2009
A venture capital funded medical device company with removable nitinol-silicone (hybrid) stents.
These hybrid stents are indicated for tracheobronchial, esophageal, duodenal, biliary, and colonic
applications. The company was acquired in March of 2009 by Merit Medical Systems, Inc. (Nasdaq:
MMSI) a worldwide designer, developer, manufacturer and marketer of medical devices used in
interventional and diagnostic procedures.
Co-Principal, Key Account Sales Manager
 Responsible for educating, training, and selling to Thoracic Surgeons, Interventional
Pulmonologists, Gastroenterologists, Bariatric Surgeons, and Surgical Oncologists who utilize
non-vascular stents for obstructive disease and leaks in the tracheobronchial, esophageal, and
biliary anatomy. My area of responsibility included Florida, Georgia, North and South Carolina.
 Experienced in identifying and implementing new device designs for stents, and delivery
systems with engineers, and key opinion leading physicians.
 Created business development and marketing programs that include physician education
outreach programs, product training and demonstration tools, and patient education literature.
 Responsible for managing and mentoring the NC Sales Associate.
 Ranked 2 out of 14 Sales Managers, 2008.
 Regained business at 11 dormant accounts, established 8 new accounts, and increased business
at 11 current accounts since hiring.
GUIDANT/ABBOTT VASCULAR, SANTA CLARA, CA APRIL 2004 - SEPTEMBER 2007
Guidant’s Endovascular Division developed the first US commercially available carotid artery stent
and embolic protection device system for use by Cardiologists, Radiologists and Vascular Surgeons.
The company was acquired by Abbott Laboratories in 2006 to create the cornerstone for Abbott
Vascular, an international market leader in the areas of drug eluting coronary stent platforms,
rapid exchange technology, balloon dilatation catheters and guide wires.
Senior Territory Manager
 Responsible for selling carotid stents, embolic protection devices, peripheral balloon dilators,
guidewires, and biliary stents to Interventional Radiologists, Neuro-Radiologists, Neuro-
Surgeons, Thoracic Surgeons, Vascular Surgeons, and Interventional Cardiologists.
 Increased territory revenue more than 242% and $1,000,000 in 2005.
 Individually trained 31 physicians on the use of the Acculink/Xact carotid stent systems, and
assisted 10 hospitals with the CMS credentialing for carotid artery stenting.
 Increased territory revenue more than 55% and $387,653 in 2004.
 Experienced in implementing economic programs that reduce cost and increase
revenue for both hospitals and physicians.
 Consistently exceeded sales plan: 108% 2004, 109% 2005, 105% 2006.
 Ranked 7 out of 110 Territory Managers, 117% to sales plan Q3 2007.
 Promoted to Senior Territory Manager in March, 2006.
BOSTON SCIENTIFIC, ENDOSCOPY DIVISION, NATICK, MA OCTOBER 1997 - APRIL 2004
Boston Scientifics’ Endoscopy Division is worldwide leader in developing and commercializing
technologies for diagnosing and treating diseases of the digestive system, airway and lungs.
Sales Trainer (May 2000 to April 2004)
 Responsible for training new territory managers on the clinical aspects and selling strategies for
stents, biliary, dilation, hemostasis, polypectomy, tissue biopsy, GERD, and enteral feeding
devices.
 Selected to ENTERYX Market Research Team 2001.
 Individually trained 11 new territory managers.
 Experienced in creating and presenting selling/training programs for the US sales force.
 Increased new product sales by 58% & $234,775 in 2003.
 Increased territory revenue more than $155,000 in 2002.
 Received REGION OF THE YEAR AWARD in 2002 and 1997.
Territory Manager (October 1997 to May 2000)
 Responsible for selling a variety of endo-prosthetic stents, diagnostic, and therapeutic
endoscopic instruments to Gastroenterologists, General Surgeons, Thoracic Surgeons, ENT
Surgeons, Colo-rectal Surgeons, Pulmonologists, and Radiologists.
 Experienced in conducting accredited continuing education courses for physicians, nurses, and
techs.
 Selected to the SALES SUCCESS MODEL TEAM 12/99. Increased new products sales more than
$107,000 in 1999.
 Received EAGLE AWARD for outstanding product focus results and leadership 2/00.
 Increased territory revenue more than $205,000 in 2000.
 Promoted to SALES TRAINER 5/00.
United States Surgical Corporation, Norwalk, CT APRIL 1996 – October 1997
US Surgical was a worldwide leading innovator of surgical staplers, suture, clips and laparoscopic
devices. The company was acquired by Tyco Inc. in 1997 and it eventually was purchased by
Covidien.
Wound Closure Technician
 Responsible for selling surgical staplers, clips, suture, laparoscopic devices, cardiovascular
instruments, stereo-tactic imaging systems, and lymphatic mapping devices to hospitals and
clinics.
 Consistently achieved and exceeded new product sales quotas.
 Increased territory revenue more than 53% & $700,000 in 1997.
 Received the TOP GUN SALES AWARD 9/97 and 6/97.
 Experienced in clinically training surgeons, nurses, and surgical scrub techs in the use of U.S.
Surgical instruments.
 Experienced in negotiating pricing contracts with hospital administrators and implementing
client partnering programs.
Astra Pharmaceuticals, RX Division, Westborough, MA February 1995 – April 1996
Astra AB was a publically traded Swedish company that developed a variety of drugs for
cardiovascular, GERD, allergy, pain, and lung diseases. Astra has since merged with Merck and
Zuniga.
Sales Representative
 Responsible for selling Rhinocort (Budesonide), an anti-inflammatory glucocorticoid steroid for
the treatment of rhinitis. Targeted physicians were ENT Surgeons, Allergists, Internal Medicine,
and Primary Care.
 Responsible for selling Toprol XL (Metoprolol Succinate), a Beta 1 selective blocking agent for
the treatment of angina and hypertension. Targeted physicians were Cardiologists,
Cardiothoracic Surgeons, and Primary Care.
 Selected to speak on the Cycle III Sales Training Audiotape.
EDUCATION/OTHER RELATED EXPERIENCE
Wright State University, Dayton, OH 1990
 Bachelor of Arts, ECONOMICS
 4 years experience as an Account Executive for Banner Enterprises in Charleston, SC. I was
responsible for selling protective equipment and clothing to police departments, fire
departments, emergency medical services, and industrial facilities. (1991-1995)

More Related Content

What's hot

Talent Brochure Werfen
Talent Brochure WerfenTalent Brochure Werfen
Talent Brochure Werfen
Patrick V. Ulrich
 
Milestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. Investor PresentationMilestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. Investor Presentation
RedChip Companies, Inc.
 
Resume mar 2017
Resume mar  2017Resume mar  2017
Resume mar 2017
Khaled Sabet
 
WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)
Patrick V. Ulrich
 
Patrick Simekha resume new (1)
Patrick Simekha resume new (1)Patrick Simekha resume new (1)
Patrick Simekha resume new (1)Patrick Simekha
 
ClinActis FSP Model
ClinActis FSP ModelClinActis FSP Model
ClinActis FSP Model
ClinActis Pte Ltd
 
Strategic planning in laboratory industry
Strategic planning in laboratory industryStrategic planning in laboratory industry
Strategic planning in laboratory industryVarsha Shahane
 
Workshop de Inovação em Medical Devices
Workshop de Inovação em Medical DevicesWorkshop de Inovação em Medical Devices
Workshop de Inovação em Medical Devices
Empreender Saúde
 
Andrea BeDan resume 10-15
Andrea BeDan resume  10-15Andrea BeDan resume  10-15
Andrea BeDan resume 10-15Andrea BeDan
 
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical Industry
Engr. Carlo Senica, MBA, CPSM
 
Immuron Corp Presentation 5.05.2019
Immuron Corp Presentation 5.05.2019Immuron Corp Presentation 5.05.2019
Immuron Corp Presentation 5.05.2019
RedChip Companies, Inc.
 
Pfizer project management
Pfizer project managementPfizer project management
Pfizer project management
Yash Vardhan Lohia
 
Market access medical devices-white paper
Market access medical devices-white paperMarket access medical devices-white paper
Market access medical devices-white paperDr. Kavita Lamror
 
Hearing & Balance Center
Hearing & Balance CenterHearing & Balance Center
Hearing & Balance Center
cookingtool
 
Lifecare Diagonistic Center in Mumbai
Lifecare Diagonistic Center in MumbaiLifecare Diagonistic Center in Mumbai
Lifecare Diagonistic Center in Mumbai
Lifecare India
 

What's hot (16)

Talent Brochure Werfen
Talent Brochure WerfenTalent Brochure Werfen
Talent Brochure Werfen
 
Milestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. Investor PresentationMilestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. Investor Presentation
 
Resume mar 2017
Resume mar  2017Resume mar  2017
Resume mar 2017
 
WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)
 
Patrick Simekha resume new (1)
Patrick Simekha resume new (1)Patrick Simekha resume new (1)
Patrick Simekha resume new (1)
 
Ahmc presentation june 2014 for healthcare private investment conference
Ahmc  presentation june 2014 for healthcare private investment conferenceAhmc  presentation june 2014 for healthcare private investment conference
Ahmc presentation june 2014 for healthcare private investment conference
 
ClinActis FSP Model
ClinActis FSP ModelClinActis FSP Model
ClinActis FSP Model
 
Strategic planning in laboratory industry
Strategic planning in laboratory industryStrategic planning in laboratory industry
Strategic planning in laboratory industry
 
Workshop de Inovação em Medical Devices
Workshop de Inovação em Medical DevicesWorkshop de Inovação em Medical Devices
Workshop de Inovação em Medical Devices
 
Andrea BeDan resume 10-15
Andrea BeDan resume  10-15Andrea BeDan resume  10-15
Andrea BeDan resume 10-15
 
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical Industry
 
Immuron Corp Presentation 5.05.2019
Immuron Corp Presentation 5.05.2019Immuron Corp Presentation 5.05.2019
Immuron Corp Presentation 5.05.2019
 
Pfizer project management
Pfizer project managementPfizer project management
Pfizer project management
 
Market access medical devices-white paper
Market access medical devices-white paperMarket access medical devices-white paper
Market access medical devices-white paper
 
Hearing & Balance Center
Hearing & Balance CenterHearing & Balance Center
Hearing & Balance Center
 
Lifecare Diagonistic Center in Mumbai
Lifecare Diagonistic Center in MumbaiLifecare Diagonistic Center in Mumbai
Lifecare Diagonistic Center in Mumbai
 

Viewers also liked

wendy sarmiento precios psicologicos
wendy sarmiento precios psicologicoswendy sarmiento precios psicologicos
wendy sarmiento precios psicologicosWendy Sarmiento
 
Makerere University
Makerere UniversityMakerere University
Makerere University
Nakachwa Esther
 
Portfolio powerpoint
Portfolio powerpointPortfolio powerpoint
Portfolio powerpoint
Bryan Wright
 
UTS Pengantar Manajemen SIB
UTS Pengantar Manajemen SIBUTS Pengantar Manajemen SIB
UTS Pengantar Manajemen SIB
3rutstore
 
Portfolio powerpoint
Portfolio powerpointPortfolio powerpoint
Portfolio powerpoint
Bryan Wright
 
Kegiatan scm
Kegiatan scmKegiatan scm
Kegiatan scm
3rutstore
 
Filosofias helenisticas
Filosofias helenisticasFilosofias helenisticas
Filosofias helenisticas
Milton Fabiano Silva
 
ZAT ADIKTIF LAINNYA
ZAT ADIKTIF LAINNYAZAT ADIKTIF LAINNYA
ZAT ADIKTIF LAINNYA
Ana Muslikha
 
PERENCANAAN TURAP
PERENCANAAN TURAPPERENCANAAN TURAP
PERENCANAAN TURAP
Dyah Rahmawati
 
20 43 anexa2
20 43 anexa220 43 anexa2
20 43 anexa2
amfms
 
Caleidoscop monografic al comunei Diosig.
 Caleidoscop monografic al comunei Diosig. Caleidoscop monografic al comunei Diosig.
Caleidoscop monografic al comunei Diosig.Biblioteci Bihorene
 
Public Relations Report 2012
Public Relations Report 2012Public Relations Report 2012
Public Relations Report 2012
Claudia Cramaroc
 
Bazele teoretice ale_evaluării_p sihologice_sinteze_de_curs
Bazele teoretice ale_evaluării_p sihologice_sinteze_de_cursBazele teoretice ale_evaluării_p sihologice_sinteze_de_curs
Bazele teoretice ale_evaluării_p sihologice_sinteze_de_curs
maryioan123
 

Viewers also liked (16)

wendy sarmiento precios psicologicos
wendy sarmiento precios psicologicoswendy sarmiento precios psicologicos
wendy sarmiento precios psicologicos
 
Makerere University
Makerere UniversityMakerere University
Makerere University
 
Portfolio powerpoint
Portfolio powerpointPortfolio powerpoint
Portfolio powerpoint
 
UTS Pengantar Manajemen SIB
UTS Pengantar Manajemen SIBUTS Pengantar Manajemen SIB
UTS Pengantar Manajemen SIB
 
Slideshare 1
Slideshare 1Slideshare 1
Slideshare 1
 
Portfolio powerpoint
Portfolio powerpointPortfolio powerpoint
Portfolio powerpoint
 
Kegiatan scm
Kegiatan scmKegiatan scm
Kegiatan scm
 
Filosofias helenisticas
Filosofias helenisticasFilosofias helenisticas
Filosofias helenisticas
 
ZAT ADIKTIF LAINNYA
ZAT ADIKTIF LAINNYAZAT ADIKTIF LAINNYA
ZAT ADIKTIF LAINNYA
 
PERENCANAAN TURAP
PERENCANAAN TURAPPERENCANAAN TURAP
PERENCANAAN TURAP
 
Dsoffercv
DsoffercvDsoffercv
Dsoffercv
 
How To Get Your First Job In Advertising
How To Get Your First Job In AdvertisingHow To Get Your First Job In Advertising
How To Get Your First Job In Advertising
 
20 43 anexa2
20 43 anexa220 43 anexa2
20 43 anexa2
 
Caleidoscop monografic al comunei Diosig.
 Caleidoscop monografic al comunei Diosig. Caleidoscop monografic al comunei Diosig.
Caleidoscop monografic al comunei Diosig.
 
Public Relations Report 2012
Public Relations Report 2012Public Relations Report 2012
Public Relations Report 2012
 
Bazele teoretice ale_evaluării_p sihologice_sinteze_de_curs
Bazele teoretice ale_evaluării_p sihologice_sinteze_de_cursBazele teoretice ale_evaluării_p sihologice_sinteze_de_curs
Bazele teoretice ale_evaluării_p sihologice_sinteze_de_curs
 

Similar to John Hickey CV 072216

danielawhiteresume
danielawhiteresumedanielawhiteresume
danielawhiteresumeDAN WHITE
 
10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf
insightscare
 
Adrian_Orr_Resume Jan 2015
Adrian_Orr_Resume Jan 2015Adrian_Orr_Resume Jan 2015
Adrian_Orr_Resume Jan 2015Adrian Orr
 
Europe's Top 5 Effective Leaders in Healthcare Edition.pdf
Europe's Top 5 Effective Leaders in Healthcare Edition.pdfEurope's Top 5 Effective Leaders in Healthcare Edition.pdf
Europe's Top 5 Effective Leaders in Healthcare Edition.pdf
insightscare
 
Europe's Top 5 Effective Leaders in Healthcare.pdf
Europe's Top 5 Effective Leaders in Healthcare.pdfEurope's Top 5 Effective Leaders in Healthcare.pdf
Europe's Top 5 Effective Leaders in Healthcare.pdf
insightscare
 
ROBERT MARQUIS RESUME' 4
ROBERT MARQUIS RESUME' 4ROBERT MARQUIS RESUME' 4
ROBERT MARQUIS RESUME' 4Robert Marquis
 
10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf
insightscare
 
Anderson_Huang,_Resume_update_by_102016
Anderson_Huang,_Resume_update_by_102016Anderson_Huang,_Resume_update_by_102016
Anderson_Huang,_Resume_update_by_102016Anderson Huang
 
William HatfieldResume052015Current
William HatfieldResume052015CurrentWilliam HatfieldResume052015Current
William HatfieldResume052015CurrentBill Hatfield
 
Resume july 2016 docx
Resume july 2016 docxResume july 2016 docx
Resume july 2016 docx
Rob Stanley
 
Bob wick resume november 2015
Bob wick resume november 2015Bob wick resume november 2015
Bob wick resume november 2015
Bob Wick, RN, BA Health Profession Education
 
Resume august 2016 word 2003 doc
Resume august 2016 word 2003 docResume august 2016 word 2003 doc
Resume august 2016 word 2003 doc
Rob Stanley
 
DevicePharm Capabilities Deck
DevicePharm Capabilities Deck DevicePharm Capabilities Deck
DevicePharm Capabilities Deck
DevicePharm
 

Similar to John Hickey CV 072216 (20)

Caron D Ambruso Cv
Caron D Ambruso CvCaron D Ambruso Cv
Caron D Ambruso Cv
 
danielawhiteresume
danielawhiteresumedanielawhiteresume
danielawhiteresume
 
10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf
 
Resume NBSA
Resume NBSAResume NBSA
Resume NBSA
 
Adrian_Orr_Resume Jan 2015
Adrian_Orr_Resume Jan 2015Adrian_Orr_Resume Jan 2015
Adrian_Orr_Resume Jan 2015
 
Resume2
Resume2Resume2
Resume2
 
Europe's Top 5 Effective Leaders in Healthcare Edition.pdf
Europe's Top 5 Effective Leaders in Healthcare Edition.pdfEurope's Top 5 Effective Leaders in Healthcare Edition.pdf
Europe's Top 5 Effective Leaders in Healthcare Edition.pdf
 
Europe's Top 5 Effective Leaders in Healthcare.pdf
Europe's Top 5 Effective Leaders in Healthcare.pdfEurope's Top 5 Effective Leaders in Healthcare.pdf
Europe's Top 5 Effective Leaders in Healthcare.pdf
 
Vosicher Resume4
Vosicher Resume4Vosicher Resume4
Vosicher Resume4
 
ROBERT MARQUIS RESUME' 4
ROBERT MARQUIS RESUME' 4ROBERT MARQUIS RESUME' 4
ROBERT MARQUIS RESUME' 4
 
10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf
 
Anderson_Huang,_Resume_update_by_102016
Anderson_Huang,_Resume_update_by_102016Anderson_Huang,_Resume_update_by_102016
Anderson_Huang,_Resume_update_by_102016
 
William HatfieldResume052015Current
William HatfieldResume052015CurrentWilliam HatfieldResume052015Current
William HatfieldResume052015Current
 
Resume july 2016 docx
Resume july 2016 docxResume july 2016 docx
Resume july 2016 docx
 
Jennifer Y
Jennifer YJennifer Y
Jennifer Y
 
BOB WICK Resume November 2015
BOB WICK Resume November 2015BOB WICK Resume November 2015
BOB WICK Resume November 2015
 
Bob wick resume november 2015
Bob wick resume november 2015Bob wick resume november 2015
Bob wick resume november 2015
 
Resume august 2016 word 2003 doc
Resume august 2016 word 2003 docResume august 2016 word 2003 doc
Resume august 2016 word 2003 doc
 
DevicePharm Capabilities Deck
DevicePharm Capabilities Deck DevicePharm Capabilities Deck
DevicePharm Capabilities Deck
 
S du Preez Jan 2016
S du Preez Jan 2016S du Preez Jan 2016
S du Preez Jan 2016
 

John Hickey CV 072216

  • 1. JOHN P. HICKEY 3339 Cottonfield Dr. 843-532-9462 Mt. Pleasant, SC 29466 jp1hickey@comcast.net SUMMARY An award winning, committed and passionate individual with twenty years of proven success in the medical device industry. A broad experience including both large and emerging technology companies in the areas of IDE study recruitment, market development, global sales, management, training, marketing, and product development. Strengths include excellent communication skills, personnel management and development of key opinion leaders with adoption of new technology. Areas of experience include Cardiology, Radiology, General & Vascular Surgery, Gastrointestinal Endoscopy, and Interventional Bronchoscopy. CAREER HISTORY PULMONX CORPORATION, REDWOOD CITY, CA SEPTEMBER 2014 – PRESENT Pulmonx is a privately-held (OUS) commercial stage medical device company focused on developing both diagnostic and therapeutic technologies for Interventional Pulmonology. Pulmonx has developed the Endobronchial Valve (EBV) Therapy, a non-surgical approach to treating emphysema that uses the Chartis Pulmonary Assessment System to optimize the placement of a series of unique self-expanding valves. In the United States, Pulmonx is conducting the LIBERATE Clinical Study to evaluate the safety and effectiveness of the Zephyr valve in patients with severe emphysema. Director of Market Development  Responsible for driving patient enrollment in US IDE study sites thru social media, print media, patient advocacy organizations, TV news stories, and physician referral networks.  Achieved and/or exceeded individual quarterly patient enrollment quotas.  Identify and develop relationships with key institutions and thought leading physicians.  Experienced in training physicians on the proper use of Pulmonx’s products, and assisting them as appropriate during the clinical study.  Work with other functional groups in the company to support regulatory, clinical, and development activities. BRONCUS MEDICAL/TECHNOLOGIES INC., MOUNTAIN VIEW, CA MAY 2009 – SEPTEMBER 2014 A venture capital funded medical device company focused on providing a portfolio approach of devices related to Interventional Pulmonology/Thoracic Surgery. Current development includes investigation of a novel minimally-invasive treatment option (airway bypass/drug eluding stents) for patients with emphysema. The organization has US commercial approval to launch imaging technology (virtual bronchoscopic navigation), tissue sampling and mini-Doppler ultrasound for diagnosis of lung disease. Director, Global Sales and Market Development (March 2012 – September 2014)  Established a team of 4 regional sales managers and 2 marketing managers to focus on achievement of commercialization objectives across the US.  Identify and develop key strategic institutions/physicians for reference centers.  Responsible for product launches in international markets recognizing CE mark approval by conducting market analysis, developing revenue models, and establishing product champions.  Identify, train, and manage international distributors to sell in Europe, Asia and South America, while providing physician proctoring and case coverage.  Assist with development of marketing and training materials for physicians and distributors.  Assist with reimbursement strategy/activities in all markets.
  • 2. Southeast Region Sales Manager (May 2009 - March 2012)  Responsible for the market development of 2 new medical technologies that provide 3D virtual bronchoscopic procedure planning and navigation, and a diagnostic biopsy device for lung disease.  Assist Global V.P. of Sales in building a direct sales force for US launch of 3 products in 2010.  Consistently finished #1 in US sales amongst 4 Regions since launch with 12 navigation systems sold to date.  Identified market opportunity to separate and expand the company’s platform product into the radiology market.  Promoted to Director, Sales & Market Development in March 2012. ALVEOLUS INC., CHARLOTTE, NC FEBRUARY 2008 - APRIL 2009 A venture capital funded medical device company with removable nitinol-silicone (hybrid) stents. These hybrid stents are indicated for tracheobronchial, esophageal, duodenal, biliary, and colonic applications. The company was acquired in March of 2009 by Merit Medical Systems, Inc. (Nasdaq: MMSI) a worldwide designer, developer, manufacturer and marketer of medical devices used in interventional and diagnostic procedures. Co-Principal, Key Account Sales Manager  Responsible for educating, training, and selling to Thoracic Surgeons, Interventional Pulmonologists, Gastroenterologists, Bariatric Surgeons, and Surgical Oncologists who utilize non-vascular stents for obstructive disease and leaks in the tracheobronchial, esophageal, and biliary anatomy. My area of responsibility included Florida, Georgia, North and South Carolina.  Experienced in identifying and implementing new device designs for stents, and delivery systems with engineers, and key opinion leading physicians.  Created business development and marketing programs that include physician education outreach programs, product training and demonstration tools, and patient education literature.  Responsible for managing and mentoring the NC Sales Associate.  Ranked 2 out of 14 Sales Managers, 2008.  Regained business at 11 dormant accounts, established 8 new accounts, and increased business at 11 current accounts since hiring. GUIDANT/ABBOTT VASCULAR, SANTA CLARA, CA APRIL 2004 - SEPTEMBER 2007 Guidant’s Endovascular Division developed the first US commercially available carotid artery stent and embolic protection device system for use by Cardiologists, Radiologists and Vascular Surgeons. The company was acquired by Abbott Laboratories in 2006 to create the cornerstone for Abbott Vascular, an international market leader in the areas of drug eluting coronary stent platforms, rapid exchange technology, balloon dilatation catheters and guide wires. Senior Territory Manager  Responsible for selling carotid stents, embolic protection devices, peripheral balloon dilators, guidewires, and biliary stents to Interventional Radiologists, Neuro-Radiologists, Neuro- Surgeons, Thoracic Surgeons, Vascular Surgeons, and Interventional Cardiologists.  Increased territory revenue more than 242% and $1,000,000 in 2005.  Individually trained 31 physicians on the use of the Acculink/Xact carotid stent systems, and assisted 10 hospitals with the CMS credentialing for carotid artery stenting.  Increased territory revenue more than 55% and $387,653 in 2004.  Experienced in implementing economic programs that reduce cost and increase revenue for both hospitals and physicians.  Consistently exceeded sales plan: 108% 2004, 109% 2005, 105% 2006.  Ranked 7 out of 110 Territory Managers, 117% to sales plan Q3 2007.  Promoted to Senior Territory Manager in March, 2006.
  • 3. BOSTON SCIENTIFIC, ENDOSCOPY DIVISION, NATICK, MA OCTOBER 1997 - APRIL 2004 Boston Scientifics’ Endoscopy Division is worldwide leader in developing and commercializing technologies for diagnosing and treating diseases of the digestive system, airway and lungs. Sales Trainer (May 2000 to April 2004)  Responsible for training new territory managers on the clinical aspects and selling strategies for stents, biliary, dilation, hemostasis, polypectomy, tissue biopsy, GERD, and enteral feeding devices.  Selected to ENTERYX Market Research Team 2001.  Individually trained 11 new territory managers.  Experienced in creating and presenting selling/training programs for the US sales force.  Increased new product sales by 58% & $234,775 in 2003.  Increased territory revenue more than $155,000 in 2002.  Received REGION OF THE YEAR AWARD in 2002 and 1997. Territory Manager (October 1997 to May 2000)  Responsible for selling a variety of endo-prosthetic stents, diagnostic, and therapeutic endoscopic instruments to Gastroenterologists, General Surgeons, Thoracic Surgeons, ENT Surgeons, Colo-rectal Surgeons, Pulmonologists, and Radiologists.  Experienced in conducting accredited continuing education courses for physicians, nurses, and techs.  Selected to the SALES SUCCESS MODEL TEAM 12/99. Increased new products sales more than $107,000 in 1999.  Received EAGLE AWARD for outstanding product focus results and leadership 2/00.  Increased territory revenue more than $205,000 in 2000.  Promoted to SALES TRAINER 5/00. United States Surgical Corporation, Norwalk, CT APRIL 1996 – October 1997 US Surgical was a worldwide leading innovator of surgical staplers, suture, clips and laparoscopic devices. The company was acquired by Tyco Inc. in 1997 and it eventually was purchased by Covidien. Wound Closure Technician  Responsible for selling surgical staplers, clips, suture, laparoscopic devices, cardiovascular instruments, stereo-tactic imaging systems, and lymphatic mapping devices to hospitals and clinics.  Consistently achieved and exceeded new product sales quotas.  Increased territory revenue more than 53% & $700,000 in 1997.  Received the TOP GUN SALES AWARD 9/97 and 6/97.  Experienced in clinically training surgeons, nurses, and surgical scrub techs in the use of U.S. Surgical instruments.  Experienced in negotiating pricing contracts with hospital administrators and implementing client partnering programs. Astra Pharmaceuticals, RX Division, Westborough, MA February 1995 – April 1996 Astra AB was a publically traded Swedish company that developed a variety of drugs for cardiovascular, GERD, allergy, pain, and lung diseases. Astra has since merged with Merck and Zuniga. Sales Representative  Responsible for selling Rhinocort (Budesonide), an anti-inflammatory glucocorticoid steroid for the treatment of rhinitis. Targeted physicians were ENT Surgeons, Allergists, Internal Medicine, and Primary Care.  Responsible for selling Toprol XL (Metoprolol Succinate), a Beta 1 selective blocking agent for the treatment of angina and hypertension. Targeted physicians were Cardiologists, Cardiothoracic Surgeons, and Primary Care.  Selected to speak on the Cycle III Sales Training Audiotape.
  • 4. EDUCATION/OTHER RELATED EXPERIENCE Wright State University, Dayton, OH 1990  Bachelor of Arts, ECONOMICS  4 years experience as an Account Executive for Banner Enterprises in Charleston, SC. I was responsible for selling protective equipment and clothing to police departments, fire departments, emergency medical services, and industrial facilities. (1991-1995)